⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6671896 | 0.73 | ALDH1A1 (0.35) | — | |
| SCHEMBL18421300 | 0.71 | — | — | |
| SCHEMBL18418431 | 0.67 | — | — | |
| SCHEMBL75894 | 0.67 | — | — | |
| SCHEMBL166196 | 0.67 | — | — | |
| SCHEMBL166194 | 0.67 | — | — | |
| SCHEMBL313056 | 0.67 | — | — | |
| SCHEMBL14501715 | 0.67 | — | — | |
| SCHEMBL11248990 | 0.65 | — | — | |
| SCHEMBL16123 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016135411-A1 | PROCESS FOR PREPARING A POLYMER BY CATIONIC POLYMERIZATION OF A HYDROPHOBIC MONOMER IN AQUEOUS DISPERSION | UNIVERSITE CLAUDE BERNARD LYON 1 (FR) | 2016-09-01 | — | — | WO | claimed |
| US-6180238-B1 | PARTICULARLY SUITABLE FOR USE IN INK JET PRINTING PROCESSES. | XEROX CORPORATION | 2001-01-30 | — | — | US | claimed |
| EP-0743574-B1 | Migration imaging members | XEROX CORP (US) | 2000-12-27 | — | — | EP | claimed |
| EP-0743573-B1 | Method for obtaining image contrast migration imaging members | XEROX CORP (US) | 2000-09-06 | — | — | EP | claimed |
| EP-0673784-B1 | Recording sheets containing oxazole, isooxazole, oxazolidinone, oxazoline salts, morpholine, thiazole, thiazolidine, thiadiazole, and phenothiazine compounds | XEROX CORP (US) | 1999-10-27 | — | — | EP | claimed |
| EP-0743574-A2 | Migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| EP-0743573-A2 | Method for obtaining image contrast migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| EP-0673784-A2 | Recording sheets containing oxazole, isooxazole, oxazolidinone, oxazoline salts, morpholine, thiazole, thiazolidine, thiadiazole, and phenothiazine compounds | XEROX CORPORATION (US) | 1995-09-27 | — | — | EP | claimed |
| EP-0262993-B1 | 2,6-PIPERAZINE-DIONE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | ADIR ET COMPAGNIE (FR) | 1990-09-12 | — | — | EP | claimed |
| EP-0262993-A1 | 2,6-Piperazine-dione derivatives, processes for their preparation and pharmaceutical compositions containing them | ADIR ET COMPAGNIE (FR) | 1988-04-06 | — | — | EP | claimed |
| US-12403461-B2 | Solid-phase chelator material, method for producing thereof and use thereof for the purification of proteins | CUBE BIOTECH GMBH (DE) | 2025-09-02 | — | — | US | disclosed |
| EP-3689974-B1 | MOLDED ARTICLE | FURUKAWA ELECTRIC CO LTD (JP) | 2025-04-23 | — | — | EP | disclosed |
| CN-114096578-B | Solvent-free composition | 陶氏环球技术有限责任公司 | 2024-08-02 | — | — | CN | disclosed |
| EP-3887033-B1 | SOLID-PHASE CHELATOR MATERIAL, METHOD FOR PRODUCING THEREOF AND USE THEREOF FOR THE PURIFICATION OF PROTEINS | CUBE BIOTECH GMBH (DE) | 2024-07-24 | — | — | EP | disclosed |
| CN-116333267-A | Sheet molding compound and fiber reinforced composite material | 三菱化学株式会社 | 2023-06-27 | — | — | CN | disclosed |
| US-4677104-A | Antipsychotic fused-ring pyridinylpiperazine derivatives | BRISTOL-MYERS COMPANY (US) | 1987-06-30 | — | — | US | disclosed |
| US-4619930-A | Antipsychotic cyclic imide derivatives of 2-(4-butylpiperazin-1-yl)pyridines, compositions and use | BRISTOL-MYERS COMPANY (US) | 1986-10-28 | — | — | US | disclosed |
| EP-0034015-B1 | PHARMACEUTICALLY ACTIVE COMPOUNDS | BEECHAM GROUP PLC (GB) | 1986-03-26 | — | — | EP | disclosed |
| US-4346089-A | GASTROINTESTINAL DISORDERS | BEECHAM GROUP LIMITED (GB) | 1982-08-24 | — | — | US | disclosed |
| EP-0034015-A2 | Pharmaceutically active compounds | BEECHAM GROUP PLC (GB) | 1981-08-19 | — | — | EP | disclosed |